Elimination of CD19-positive lymphoid malignancies by CD19-CAR expressing NK cells
- 专利权人:
- Nantkwest; Inc.
- 发明人:
- KLINGEMANN, Hans G.,BOISSEL, Laurent H.,SOON-SHIONG, Patrick
- 申请号:
- AU2019371340
- 公开号:
- AU2019371340A1
- 申请日:
- 2019.08.01
- 申请国别(地区):
- AU
- 年份:
- 2020
- 代理人:
- 摘要:
- Provided herein are compositions of NK-92® cells that express a CD19 CAR, CD16 and IL2, and the method of using these cells to and treat cancer in a patient.
- 来源网站:
- 中国工程科技知识中心